Ann Zauber

Q: What Schools Are Affiliated With Ann Zauber

Ann Zauber is affiliated with the following schools: Johns Hopkins University, University of Washington, Massachusetts General Hospital, University of Lausanne, University of Oslo, Institute of Cancer Research, University of California, Berkeley, University of Minnesota, University of Wisconsin–Madison, Stanford University

Ann Zauber's AcademicInfluence.com Rankings

Ann Zauber

Medical

#2142

World Rank

#2544

Historical Rank

Epidemiology

#444

World Rank

#466

Historical Rank

medical Degrees

Ann Zauber

Mathematics

#6442

World Rank

#8919

Historical Rank

Statistics

#630

World Rank

#714

Historical Rank

mathematics Degrees

Download Badge

Medical
Mathematics

Ann Zauber's Degrees

PhD Biostatistics Johns Hopkins University

Why Is Ann Zauber Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Ann Graham Zauber is an epidemiologist and biostatistician at the Memorial Sloan Kettering Cancer Center, primarily interested in colorectal cancer. Her research has demonstrated the effectiveness of colonoscopy and polyp removal at reducing the incidence of this kind of cancer.

(See a Problem?)

Ann Zauber's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. (1993) (4416)
Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. (2012) (2063)
Cardiovascular Risk Associated With Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention (2005) (2002)
Annual report to the nation on the status of cancer, 1975‐2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates (2010) (1871)
Celecoxib for the prevention of sporadic colorectal adenomas. (2006) (1030)
Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. (1993) (954)
Celecoxib for the prevention of colorectal adenomatous polyps. (2006) (804)
The National Polyp Study. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. (1990) (798)
Adenoma detection rate and risk of colorectal cancer and death. (2014) (758)
Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. (2006) (684)
Guidelines for Colonoscopy Surveillance after Polypectomy: A Consensus Update by the US Multi‐Society Task Force on Colorectal Cancer and the American Cancer Society * , † (2006) (642)
Evaluating Test Strategies for Colorectal Cancer Screening: A Decision Analysis for the U.S. Preventive Services Task Force (2008) (600)
A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. (1991) (536)
A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy. National Polyp Study Work Group. (2000) (522)
A pooled analysis of advanced colorectal neoplasia diagnoses after colonoscopic polypectomy. (2009) (508)
The National Polyp Study (1990) (499)
Nonpolypoid neoplastic lesions of the colorectal mucosa. (2008) (477)
Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies: Modeling Study for the US Preventive Services Task Force. (2016) (371)
Colorectal cancers soon after colonoscopy: a pooled multicohort analysis (2013) (369)
Preoperative staging of esophageal cancer: comparison of endoscopic US and dynamic CT. (1991) (337)
The advanced adenoma as the primary target of screening. (2002) (333)
Risk of colorectal cancer in the families of patients with adenomatous polyps. National Polyp Study Workgroup. (1996) (300)
Effect of Celecoxib on Cardiovascular Events and Blood Pressure in Two Trials for the Prevention of Colorectal Adenomas (2006) (290)
Preoperative staging of gastric cancer: comparison of endoscopic US and dynamic CT. (1991) (290)
The epidemiology of testicular cancer in young adults. (1980) (285)
Effects of Organized Colorectal Cancer Screening on Cancer Incidence and Mortality in a Large Community-Based Population. (2018) (259)
Determinants of late stage diagnosis of breast and cervical cancer: the impact of age, race, social class, and hospital type. (1991) (255)
Vasectomy and the risk of prostate cancer. (1990) (249)
Association of Obesity With Risk of Early-Onset Colorectal Cancer Among Women (2019) (247)
Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: a large community-based study (2016) (235)
Population-Based Colonoscopy Screening for Colorectal Cancer: A Randomized Clinical Trial. (2016) (215)
Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening. (2009) (203)
A case-control study of oral contraceptive use and invasive epithelial ovarian cancer. (1994) (197)
Association Between Time to Colonoscopy After a Positive Fecal Test Result and Risk of Colorectal Cancer and Cancer Stage at Diagnosis (2017) (195)
How much can current interventions reduce colorectal cancer mortality in the U.S.? (2006) (194)
Five-Year Efficacy and Safety Analysis of the Adenoma Prevention with Celecoxib Trial (2009) (190)
The Impact of Screening on Colorectal Cancer Mortality and Incidence: Has It Really Made a Difference? (2015) (183)
Fecal Immunochemical Test Program Performance Over 4 Rounds of Annual Screening (2016) (181)
Incidence of second cancers in patients treated for Hodgkin's disease. (1995) (177)
Public Health Impact of Achieving 80% Colorectal Cancer Screening Rates in the United States by 2018 (2015) (175)
Colorectal cancer screening: Estimated future colonoscopy need and current volume and capacity (2016) (174)
Contribution of Screening and Survival Differences to Racial Disparities in Colorectal Cancer Rates (2012) (173)
Contribution of behavioral risk factors and obesity to socioeconomic differences in colorectal cancer incidence. (2012) (172)
The NordICC Study: Rationale and design of a randomized trial on colonoscopy screening for colorectal cancer (2012) (164)
Nonsteroidal anti-inflammatory drugs and risk of digestive cancers at sites other than the large bowel. (2000) (151)
Flat adenomas in the National Polyp Study: is there increased risk for high-grade dysplasia initially or during surveillance? (2004) (149)
National Polyp Study data: Evidence for regression of adenomas (2004) (148)
The impact of the rising colorectal cancer incidence in young adults on the optimal age to start screening: Microsimulation analysis I to inform the American Cancer Society colorectal cancer screening guideline (2018) (147)
The national polyp study design, methods, and characteristics of patients with newly diagnosed polyps (1992) (146)
Statin Use and the Risk of Breast and Prostate Cancer (2002) (145)
Cost-effectiveness of computed tomographic colonography screening for colorectal cancer in the medicare population. (2010) (128)
Understanding the contribution of family history to colorectal cancer risk and its clinical implications: A state‐of‐the‐science review (2016) (120)
Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefits. (2014) (117)
Transforming Epidemiology for 21st Century Medicine and Public Health (2013) (116)
Findings from NSABP protocol no. B‐04‐comparison of radical mastectomy with alternative treatments for primary breast cancer. I. Radiation compliance and its relation to treatment outcome (1980) (115)
Estrogen replacement therapy and the risk of breast cancer: results from the case-control surveillance study. (1991) (113)
Radiation-related cancer risks from CT colonography screening: a risk-benefit analysis. (2011) (113)
Pragmatic classification of superficial neoplastic colorectal lesions. (2009) (112)
Family history and the natural history of colorectal cancer: systematic review (2015) (112)
A Systematic Comparison of Microsimulation Models of Colorectal Cancer (2011) (107)
Risk and surveillance of individuals with colorectal polyps. Who Collaborating Centre for the Prevention of Colorectal Cancer. (1990) (105)
Should colorectal cancer screening be considered in elderly persons without previous screening? A cost-effectiveness analysis. (2014) (104)
A case-control study of analgesic use and ovarian cancer. (2000) (103)
Increased incidence of cancer among homosexual men, New York City and San Francisco, 1978-1990. (1996) (101)
The relationship of nonsteroidal anti-inflammatory drug use to the risk of breast cancer. (1999) (101)
Cystic Fibrosis Colorectal Cancer Screening Consensus Recommendations. (2017) (101)
Breast cancer and cigarette smoking: a hypothesis. (1991) (100)
Calcium channel blockers and the risk of cancer. (1998) (100)
TERC polymorphisms are associated both with susceptibility to colorectal cancer and with longer telomeres (2011) (99)
Colorectal cancer deaths attributable to nonuse of screening in the United States. (2015) (92)
Predictors of smoking prevalence among New York Latino youth. (1992) (91)
Quality of life and symptom control after stent placement or surgical palliation of malignant colorectal obstruction. (2010) (86)
Rationale and design of the European Polyp Surveillance (EPoS) trials (2016) (84)
Phytoestrogen consumption and endometrial cancer risk: a population-based case–control study in New Jersey (2009) (82)
Interventions to Improve Follow-up of Positive Results on Fecal Blood Tests (2017) (80)
Individualizing colonoscopy screening by sex and race. (2009) (80)
A novel hypothesis on the sensitivity of the fecal occult blood test (2009) (80)
Stool DNA Testing to Screen for Colorectal Cancer in the Medicare Population (2010) (78)
Risk of Endometrial Cancer in Relation to Medical Conditions and Medication Use (2009) (78)
Cumulative Burden of Colorectal Cancer-Associated Genetic Variants is More Strongly Associated With Early-onset vs Late-onset Cancer. (2019) (78)
At what costs will screening with CT colonography be competitive? A cost‐effectiveness approach (2009) (77)
Risk of Breast Cancer According to Use of Antidepressants, Phenothizaines, and Anthistamines (1999) (76)
Variation in Adenoma Detection Rate and the Lifetime Benefits and Cost of Colorectal Cancer Screening: A Microsimulation Model. (2015) (73)
Cost-Effectiveness of DNA Stool Testing to Screen for Colorectal Cancer (2007) (73)
Personalizing colonoscopy screening for elderly individuals based on screening history, cancer risk, and comorbidity status could increase cost effectiveness. (2015) (73)
Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test. (2016) (72)
Colorectal Cancer Screening: An Updated Modeling Study for the US Preventive Services Task Force. (2021) (72)
Case-control study of oral contraceptive use and risk of breast cancer. (1996) (70)
Unifying screening processes within the PROSPR consortium: a conceptual model for breast, cervical, and colorectal cancer screening. (2015) (69)
Long-term Risk of Colorectal Cancer and Related Death After Adenoma Removal in a Large, Community-based Population. (2020) (68)
Iron supplementation after femoral head replacement for patients with normal iron stores. (1992) (65)
The value of models in informing resource allocation in colorectal cancer screening: the case of the Netherlands (2015) (62)
Estrogen replacement therapy and risk of lung cancer (2002) (62)
Relation of time since last birth and parity to survival of young women with breast cancer. (1998) (62)
Modifiable Failures in the Colorectal Cancer Screening Process and Their Association With Risk of Death. (2019) (60)
Second malignancies after childhood Hodgkin's disease: The memorial sloan‐kettering cancer center experience (1988) (59)
The relation of vasectomy to the risk of cancer. (1994) (58)
Cigarette smoking patterns in patients after treatment of bladder cancer. (2000) (58)
Risk of breast cancer according to use of antidepressants, phenothiazines, and antihistamines. (1999) (57)
Allergies, variants in IL-4 and IL-4Rα genes, and risk of pancreatic cancer (2007) (56)
Aberrant Crypt Foci in the Adenoma Prevention with Celecoxib Trial (2008) (56)
The National Polyp Study. (1993) (56)
Colonoscopic polypectomy and the incidence of colorectal cancer (2001) (54)
A Comparison of Fecal Immunochemical and High-Sensitivity Guaiac Tests for Colorectal Cancer Screening (2017) (53)
Validation of Models Used to Inform Colorectal Cancer Screening Guidelines (2016) (53)
Improvement in the Diagnostic Evaluation of a Positive Fecal Occult Blood Test in an Integrated Health Care Organization (2008) (53)
Optimizing colorectal cancer screening by race and sex: Microsimulation analysis II to inform the American Cancer Society colorectal cancer screening guideline (2018) (52)
NSAIDs and risk of colorectal cancer according to presence or absence of family history of the disease (2000) (51)
Initial management and follow-up surveillance of patients with colorectal adenomas. (1997) (51)
The economic impact of a patient navigator program to increase screening colonoscopy (2012) (51)
Long-term Risk of Colorectal Cancer and Related Deaths After a Colonoscopy With Normal Findings (2019) (51)
Cost-effectiveness of colonoscopy. (2010) (49)
Race/Ethnicity and Adoption of a Population Health Management Approach to Colorectal Cancer Screening in a Community-Based Healthcare System (2016) (49)
Cytochrome P450 2C9 variants influence response to celecoxib for prevention of colorectal adenoma. (2009) (47)
Accuracy of Fecal Occult Blood Test Interpretation (1991) (45)
Allergies, variants in IL-4 and IL-4R alpha genes, and risk of pancreatic cancer. (2007) (45)
Much of the genetic risk of colorectal cancer is likely to be mediated through susceptibility to adenomas. (2013) (44)
Clarifying Differences in Natural History between Models of Screening (2011) (44)
Precursors of colorectal carcinoma Biopsy and biologic markers (1992) (43)
Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening (2017) (43)
Role of stem-cell divisions in cancer risk (2017) (43)
The natural history of colorectal cancer. Opportunities for intervention (1991) (41)
Risk of ovarian cancer according to use of antidepressants, phenothiazines, and benzodiazepines (United States) (2000) (39)
Population-Based Precision Cancer Screening: A Symposium on Evidence, Epidemiology, and Next Steps (2016) (38)
Comparative economic evaluation of data from the ACRIN National CT Colonography Trial with three cancer intervention and surveillance modeling network microsimulations. (2011) (37)
A Proposed Approach for Implementing Genomics-Based Screening Programs for Healthy Adults (2018) (37)
Cost-Effectiveness of CT Colonography to Screen for Colorectal Cancer (2009) (37)
Colonoscopy surveillance after polypectomy and colorectal cancer resection. (2008) (36)
Effect of Colonoscopy Screening on Risks of Colorectal Cancer and Related Death. (2022) (36)
Evaluating Test Strategies for Colorectal Cancer Screening—Age to Begin, Age to Stop, and Timing of Screening Intervals (2009) (36)
Oral contraceptive use and risk of cutaneous malignant melanoma (1992) (35)
Adherence to the dietary guidelines for Americans and endometrial cancer risk (2010) (35)
Relation of benzodiazepine use to the risk of selected cancers: breast, large bowel, malignant melanoma, lung, endometrium, ovary, non-Hodgkin's lymphoma, testis, Hodgkin's disease, thyroid, and liver. (1995) (35)
Statin Use and Colorectal Adenoma Risk: Results from the Adenoma Prevention with Celecoxib Trial (2010) (35)
Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study (2017) (34)
Factors influencing variation in physician adenoma detection rates: a theory-based approach for performance improvement. (2016) (33)
Health supervision for people with Bloom syndrome (2018) (33)
Adult height and risk of breast cancer among US black women. (1995) (33)
Variants in hormone biosynthesis genes and risk of endometrial cancer (2008) (32)
Phenolphthalein laxatives and risk of cancer. (2000) (31)
A summary of the Fight Colorectal Cancer working meeting: exploring risk factors and etiology of sporadic early-age onset colorectal cancer. (2019) (31)
Systematic meta-analyses and field synopsis of genetic association studies in colorectal adenomas. (2016) (30)
The National Polyp Study: overview of program and preliminary report of patient and polyp characteristics. (1988) (30)
969 Public Health Impact of Achieving 80% Colorectal Cancer Screening Rates in the United States by 2018 (2015) (30)
Cost-Effectiveness of Risk-Stratified Colorectal Cancer Screening Based on Polygenic Risk: Current Status and Future Potential (2019) (30)
Comparing the Cost-Effectiveness of Innovative Colorectal Cancer Screening Tests (2020) (28)
Clinical and genetic findings in an Ashkenazi Jewish population with colorectal neoplasms (2005) (28)
Cost-effectiveness of a multitarget stool DNA test for colorectal cancer screening of Medicare beneficiaries (2019) (28)
C-reactive Protein and Risk of Colorectal Adenoma According to Celecoxib Treatment (2011) (26)
Index colonoscopy-related risk factors for postcolonoscopy colorectal cancers. (2019) (26)
Transitional cell cancer of the urinary tract and renal cell cancer in relation to acetaminophen use (United States) (2004) (26)
Using census and mortality data to target small areas for breast, colorectal, and cervical cancer screening. (1994) (25)
Colorectal Cancer Health Disparities and the Role of US Law and Health Policy. (2016) (25)
Evaluating screening participation, follow-up and outcomes for breast, cervical and colorectal cancer in the PROSPR consortium. (2019) (24)
Endoscopist fatigue estimates and colonoscopic adenoma detection in a large community-based setting. (2017) (24)
Quality of life in participants of a CRC screening program (2012) (24)
Development and validation of an algorithm for classifying colonoscopy indication. (2015) (24)
The appropriateness of more intensive colonoscopy screening than recommended in Medicare beneficiaries: a modeling study. (2014) (23)
Cost Effectiveness of Age-Specific Screening Intervals for People With Family Histories of Colorectal Cancer. (2018) (23)
A Comparison of the Cost-Effectiveness of Fecal Occult Blood Tests with Different Test Characteristics in the Context of Annual Screening in the Medicare Population (2003) (23)
Adjusting for patient demographics has minimal effects on rates of adenoma detection in a large, community-based setting. (2015) (22)
Induced and spontaneous abortion in relation to risk of breast cancer (United States) (1997) (22)
Chemopreventive Efficacy of the Cyclooxygenase-2 (Cox-2) Inhibitor, Celecoxib, Is Predicted by Adenoma Expression of Cox-2 and 15-PGDH (2018) (22)
On finding flat adenomas: is the search worth the gain? (2002) (21)
Fecal Immunochemical Test (FIT) for Colon Cancer Screening: Variable Performance with Ambient Temperature (2016) (20)
Evaluation of the Effectiveness and Cost-Effectiveness of Personalized Surveillance After Colorectal Adenomatous Polypectomy (2017) (20)
Accurate Identification of Colonoscopy Quality and Polyp Findings Using Natural Language Processing (2017) (20)
Drug Utilization Review in an HMO I. Introduction and Examples of Methodology (1977) (19)
Observational methods to assess the effectiveness of screening colonoscopy in reducing right colon cancer mortality risk: SCOLAR. (2015) (19)
Adult height and risk of breast cancer among white women in a case-control study. (1996) (19)
Multicohort Models in Cost-Effectiveness Analysis (2013) (19)
Coffee and tea consumption and endometrial cancer risk in a population-based study in New Jersey (2010) (18)
Effect of initial polypectomy versus surveillance polypectomy on colorectal cancer incidence reduction: Micro-simulation modeling of national polyp study data (2000) (18)
Cancer: Risk factors and random chances (2015) (18)
Colorectal cancer screening: now is the time. (2000) (17)
Molecular changes in the Ki‐ras and APC genes in colorectal adenomas and carcinomas arising in the same patient (2001) (17)
Building Better Models (2012) (17)
Development and Validation of a Clinical Score for Predicting Risk of Adenoma at Screening Colonoscopy (2015) (17)
Cost Effectiveness of Screening Individuals With Cystic Fibrosis for Colorectal Cancer. (2017) (17)
Geographically-based cancer control: methods for targeting and evaluating the impact of screening interventions on defined populations. (1988) (17)
Expanding colorectal cancer screening among minority women (2011) (17)
Implications of New Colorectal Cancer Screening Technologies for Primary Care Practice (2008) (17)
Receipt of Colonoscopy Following Diagnosis of Advanced Adenomas: An Analysis within Integrated Healthcare Delivery Systems (2018) (16)
9 Physician Adenoma Detection Rate Variability and Subsequent Colorectal Cancer Risk Following a Negative Colonoscopy (2013) (16)
Comparative molecular pathology of sporadic hyperplastic polyps and neoplastic lesions from the same individual (2004) (15)
Oral contraceptive use and breast cancer risk among African-American women (1995) (15)
Accuracy of fecal occult blood test interpretation. National Polyp Study Work Group. (1991) (15)
The Influence of UGT1A6 Variants and Aspirin Use in a Randomized Trial of Celecoxib for Prevention of Colorectal Adenoma (2011) (15)
A placebo-controlled trial of 10-day bismuth-based quadruple therapy to eradicate Helicobacter pylori infection; a pilot study for the large Linqu County trial (2010) (14)
Effect of Initial Polypectomy Versus Surveillance Polypectomy on Colorectal Cancer Mortality Reduction: Micro-Simulation Modeling of the National Polyp Study: 1207 (2007) (14)
Optimal colorectal cancer screening in states' low-income, uninsured populations—the case of South Carolina. (2015) (14)
Value Of Waiving Coinsurance For Colorectal Cancer Screening In Medicare Beneficiaries. (2017) (14)
High-Intensity Versus Low-Intensity Surveillance for Patients With Colorectal Adenomas (2019) (13)
Changes in risk factors and increases in screening contribute to the decline in colorectal cancer mortality, 1975 to 2000. (2010) (13)
Germline Variants and Advanced Colorectal Adenomas: Adenoma Prevention with Celecoxib Trial Genome-wide Association Study (2013) (12)
Cost-Savings to Medicare From Pre-Medicare Colorectal Cancer Screening (2015) (12)
Derivation of Background Mortality by Smoking and Obesity in Cancer Simulation Models (2013) (12)
Hematologic data of healthy very old people. (1988) (12)
The National Polyp Study: Aims and Organization1 (1986) (12)
Side of origin of epithelial ovarian cancer. (1992) (11)
A symptom‐based model to predict colorectal cancer in low‐resource countries: Results from a prospective study of patients at high risk for colorectal cancer (2018) (11)
Guaiac-based faecal occult blood tests versus faecal immunochemical tests for colorectal cancer screening in average-risk individuals. (2011) (11)
Blinded assessment of the flat adenoma in the national polyp study (NPS) does not demonstrate an excess risk for high grade dysplasia initially or for advanced adenomas at surveillance (2001) (11)
Uncontrolled confounding in studies of screening effectiveness: an example of colonoscopy (2013) (10)
272 Cost-Effectiveness of CT Colonography to Screen for Colorectal Cancer: Report to Center for Medicare and Medicaid Services from Cancer Intervention and Surveillance Modeling Network (CISNET) (2009) (10)
Cancer Models and Real-world Data: Better Together. (2016) (10)
Incidence Reduction Following Colonoscopic Polypectomy (2011) (10)
Decreased colorectal cancer incidence and mortality in a diverse urban population with increased colonoscopy screening (2021) (9)
178 Evaluating the Benefits and Harms of Colorectal Cancer Screening Strategies: A Collaborative Modeling Approach to Inform the US Preventive Services Task Force (2016) (9)
The impact of stratifying by family history in colorectal cancer screening programs (2015) (9)
Survival of premenopausal women with breast carcinoma (1998) (8)
High-quality colonoscopies must be an integral part of screening and surveillance programs. (2006) (8)
Colorectal cancer screening world gastroenterology organisation/international digestive cancer alliance practice guidelines (2008) (8)
Use of ambulatory health services by the near poor. (1978) (8)
Impact of adenoma detection on the benefit of faecal testing vs. colonoscopy for colorectal cancer (2017) (7)
Clinical characteristics of patients with epidermoid carcinoma of the upper aerodigestive tract who develop second malignant tumors. (1992) (7)
A statistical model for post-polypectomy surveillance: a virtual alternative to virtual colonoscopy? (2006) (5)
The National Polyp Study at 40: challenges then and now. (2020) (5)
Quality control for flexible sigmoidoscopy: which polyps count? (2004) (5)
Promoting colonoscopy screening among low‐income Latinos at average risk of colorectal cancer: A randomized clinical trial (2019) (5)
Consensus Recommendations for Colorectal Cancer Screening in Adults with Cystic Fibrosis (2017) (5)
Yield and Cost-effectiveness of Computed Tomography Colonography Versus Colonoscopy for Post Colorectal Cancer Surveillance (2018) (5)
Colorectal Cancer Screening Participation Among Asian Americans Overall and Subgroups in an Integrated Health Care Setting with Organized Screening (2018) (5)
Breast cancer screening initiation after turning 40 years of age within the PROSPR consortium (2016) (4)
175 Colonoscopy Delay After a Positive Fecal Test and Risk of Colorectal Cancer-Related Outcomes (2016) (4)
Validation of Colorectal Cancer Models on Long-term Outcomes from a Randomized Controlled Trial (2020) (4)
351 Adherence to Screening in a Randomized Controlled Trial of a One-Time Screening Colonoscopy Versus Program of Annual Fecal Occult Blood Test (gFOBt): Implications of Lower gFOBt Adherence to Screening on Colorectal Cancer Mortality Reduction (2012) (4)
The Appropriateness ofMore Intensive Colonoscopy Screening Than Recommended inMedicare Beneficiaries AModeling Study (2014) (4)
The APC and PreSAP trials: a post hoc noninferiority analysis using a comprehensive new measure for gastrointestinal tract injury in 2 randomized, double-blind studies comparing celecoxib and placebo. (2012) (4)
Abstract LB-141: The Adenoma Prevention with Celecoxib (APC) trial: Five-year efficacy and safety results (2008) (4)
691 – Increasing Physician Adenoma Detection Rate is Associated with a Reduced Risk of Post-Colonoscopy Colorectal Cancer (2019) (4)
Adenoma Prevalence in Blacks and Whites Having Equal Adherence To Screening Colonoscopy: The National Colonoscopy Study (2017) (4)
UEG Week 2016 Poster Presentations (2016) (4)
Simulation of colorectal cancer screening: what we do and do not know and does it matter. (2010) (4)
Colorectal Cancer Screening in Young Adults (2021) (3)
1010 Prevention of Colorectal Cancer By Colonoscopy Is the Most Likely Screening Strategy to Offset Escalating Treatment Costs (2008) (3)
Will Test-Specific Adherence Predict the Best Colorectal Cancer Screening Strategy? (2009) (3)
Detection of Proximal Adenomas by Colonoscopy Following Flexible Sigmoidoscopy Depends on the Colonoscopy Referral Algorithm: Analysis of the UK Flexible Sigmoidoscopy Study Algorithm Applied to the U.S. National Colonoscopy Study (2011) (3)
Prostaglandin Inhibition and Cardiovascular Risk: Maybe Timing Really Is Everything (2009) (3)
Extracolonic findings from CTC: balancing risks and benefits. (2009) (3)
Health Care of the Aged in Four Ambulatory Settings with a Focus on the Hypertensive Patient (1975) (3)
Colonoscopic Polypectomy and Long-Term Prevention of Colorectal Cancer Deaths (2012) (3)
The effect of using fecal testing after a negative sigmoidoscopy on the risk of death from colorectal cancer (2020) (2)
828 Adherence to Annual Fecal Immunochemical Testing in a Large, Community-Based Population (2013) (2)
United States Preventive Services Task Force recommendations: age to end screening misunderstood. (2010) (2)
Symposium: health care of the aged in four ambulatory settings with a focus on the hypertensive patient. Introduction. (1975) (2)
Until What Age is Colonoscopy Indicated in Elderly People Without Prior Screening (2011) (2)
A comparison of primary breast cancer management in small, intermediate and large community hospitals and a comprehensive cancer center. (1984) (2)
1023 Impact of Variation in Screening Colonoscopy Quality on the Prevention of Colorectal Cancer Deaths. A Modelling Study (2013) (2)
Abstract LB-173: Statin use and colorectal adenoma risk: Results from the Adenoma Prevention with Celecoxib (APC) trial (2010) (2)
Colorectal Cancer Screening within Colonoscopy Capacity Constraints: Can FIT-Based Programs Save More Lives by Trading off More Sensitive Test Cutoffs against Longer Screening Intervals? (2020) (2)
Impact and Recovery from COVID-19–Related Disruptions in Colorectal Cancer Screening and Care in the US: A Scenario Analysis (2022) (2)
Young-onset colorectal cancer (2023) (2)
An MSKCC-community hospital colorectal carcinoma audit: a cancer control project. (1983) (2)
92 – Comparing the Cost-Effectiveness of New Colorectal Cancer Screening Tests (2019) (1)
315 The Effect of Ambient Temperature on the Performance of Mailed Fecal Immunochemical Tests for Population-Based Screening (2014) (1)
W1096 Advanced Colorectal Neoplasia Following Polypectomy: A Pooled Analysis (2008) (1)
Disparities in Colorectal Cancer Screening Rates Among Asian Subgroups in a Large Managed Care Organization (2015) (1)
Sa1222 The National Colorectal Cancer Roundtable Campaign to Screen 80% for Colorectal Cancer by 2018: Mapping Progress by State to Focus Screening Effort (2016) (1)
Expression of COX-2 and 15-PGDH in adenomas removed during pretreatment colonoscopy to predict chemopreventive efficacy of the selective COX-2 inhibitor, celecoxib. (2017) (1)
Randomized Trial of Facilitated Adherence to Screening-Colonoscopy Versus Sequential Fecal-Based Blood Test. (2023) (1)
Comparative Effectiveness and Cost-Effectiveness of Current CRC Screening Modalities (2015) (1)
Cost‐effectiveness of prophylactic hysterectomy in first‐degree female relatives with Lynch syndrome of patients diagnosed with colorectal cancer in the United States: a microsimulation study (2021) (1)
Mo1156 Meta-Analysis on Guaiac-Based Fecal Occult Blood Tests Versus Fecal Immunochemical Tests for Colorectal Cancer Screening in Average-Risk Individuals (2016) (1)
Cost-Effectiveness of Screening Individuals With Cystic Fibrosis for Colorectal Cancer. (2017) (1)
Elucidating the Drivers for the Rising Incidence of Early-Onset Colorectal Cancer: How Ecologic Studies Could Help and What Is Next. (2023) (1)
295: Using area sampling to locate controls (2005) (1)
Can post-polypectomy surveillance be less intensive? (2017) (1)
Age-stratified prevalence and predictors of neoplasia among US adults undergoing screening colonoscopy in a national endoscopy registry. (2022) (1)
National Polyp Study Data (2004) (1)
M1047 Rationale and Methods of the First Randomized Trial On Colonoscopy Screening for Colorectal Cancer: the Nordicc (Nordic-European Initiative On Colorectal Cancer) Trial (2009) (1)
Predictive role of aberrant crypt foci (ACF) as surrogate endpoint biomarkers of colorectal cancer. (2006) (1)
ANALYSES OF PREVENTIVE CARE MEASURES WITH INCOMPLETE HISTORICAL DATA IN ELECTRONIC MEDICAL RECORDS: AN EXAMPLE FROM COLORECTAL CANCER SCREENING. (2020) (1)
Questions raised by study on cancer mortality in oil refinery workers. (1980) (1)
A Psychosocial Model of Resilience Theory and Research: A Recommended Paradigm for Studying African Americans’ Beliefs and Practices Toward Colon Cancer Screening (2007) (1)
283 - Obesity is Associated with an Increased Risk of Young-Onset Colorectal Cancer (2018) (1)
172 Using Patient Navigation to Minimize Racial Disparities in Screening and Surveillance Colonoscopy in a Large Diverse Urban Population (2013) (1)
W1104 The Influence of Genetic Variation in the Cytochrome P450 2c9 Enzyme in a Randomized Trial of Celecoxib for the Prevention of Sporadic Colorectal Adenoma (2008) (1)
Mo1689 Long-Term Colorectal Cancer Incidence and Mortality for a Single Colonoscopy Versus Annual FOBT Is Influenced by Adherence; A Microsimulation Model Based on Observed National Colonoscopy Study Data (2016) (0)
Table 1, Summary results for all colonoscopy strategies per 1000 40-year old individuals, MISCAN (2009) (0)
Table 6, Summary results for all Hemoccult SENSA strategies per 1000 40-year old individuals, SimCRC (2009) (0)
Appendix 1: Model descriptions (2009) (0)
Comment re: “Sporadic Aberrant Crypt Foci Are Not a Surrogate Endpoint for Colorectal Adenoma Prevention” and “Aberrant Crypt Foci in the Adenoma Prevention with Celecoxib Trial” (2008) (0)
Sa1715 The Effect on Outcomes of Using Fecal Immunochemical Tests (Fit) for Surveillance of Colorectal Adenoma Patients Within Miscan Micro-Simulation Evaluation (2017) (0)
Cancer Epidemiology in the 21 st Century Transforming Epidemiology for 21 st Century Medicine and Public Health (2013) (0)
Response to the letter to the editor by Hassan et al.: The diminutive lesion versus the advanced adenoma: Which is the real target of CT colonography screening? (2009) (0)
Implementing a Multisite, Transdisciplinary Case-Control Study to Assess Effectiveness of Screening Colonoscopy for Preventing Death From Colorectal Cancer (SCOLAR) (2015) (0)
Using Epidemiologic Evidence to Guide Recommendations for Colorectal Cancer Screening in Adults with Cystic Fibrosis (2017) (0)
Variation in AdenomaDetection Rate and the Lifetime Benefits and Cost of Colorectal Cancer Screening AMicrosimulationModel (2015) (0)
OP-IJEJ150184 1..20 (2015) (0)
Mo2004 Using Social Media to Advance Effective Outreach, Education and Support to Address the Increasing Incidence of Colorectal Cancer (CRC) Among Young Adults: The Initial Experience of the Colon Cancer Challenge Foundation (2015) (0)
Nonsteroidal Anti-Inflammatory Drugs and Risk of Digestive Cancers at Sites Other Than the Large Bowel 1 (2000) (0)
Does the risk of colorectal neoplasia increase in probands when a second parent is affected with colorectal cancer (1998) (0)
Update by the US Multi-Society Task Force on Colorectal Cancer and the Guidelines for Colonoscopy Surveillance after Polypectomy: A Consensus (2006) (0)
Practicum in assessing family history of cancer to inform colorectal cancer screening (2003) (0)
Impact of Having a Second Degree Relative with Colorectal Cancer on the Risks of Developing Adenomas (2005) (0)
W1913 A Prospective Study of C-Reactive Protein and Risk of Colorectal Adenoma According to Celecoxib Treatment (2009) (0)
Validation of a genetic-enhanced risk prediction model for colorectal cancer in a large community-based cohort. (2023) (0)
Table 3, Efficient and Near-Efficient Strategies for Age to Begin Screening of 50 and 60* (2009) (0)
Mo1966 Colorectal Cancer Screening Among Asian Subgroups in a Large Managed Care Organization (2015) (0)
Cost‐Savings to Medicare from Increased Colorectal Cancer Screening in the Pre‐Medicare Population: 2010 ACG International Award: 1095 (2010) (0)
111 PREVALENCE AND PREDICTORS OF ADVANCED NEOPLASIA IN ADULTS YOUNGER THAN 50 YEARS UNDERGOING SCREENING COLONOSCOPY IN THE GIQUIC NATIONAL REGISTRY (2020) (0)
Cost-Effectiveness of Waiving all Copayments for Colorectal Cancer Screening Among Medicare Beneficiaries (2017) (0)
Table 7, Summary results for all FIT strategies per 1000 40-year old individuals, MISCAN (2009) (0)
P67 Design and implementation of a computerized system for a colon cancer prevention program (1995) (0)
Factors Associated with Detection of Hereditary Diffuse Gastric Cancer on Endoscopy in Individuals with Germline CDH1 Mutations. (2023) (0)
In Memoriam: Wendy Atkin 1947-2018. (2019) (0)
Tu1034 Impact of Fatigue on Colonoscopic Adenoma Detection in a Large Community-Based Managed Healthcare System (2014) (0)
Combining Asian-European Genome-Wide Association Studies of Colorectal Cancer Improves Risk Prediction Across Race and Ethnicity (2023) (0)
Preference for Colonoscopy in a Program of Annual Fecal Occult Blood Testing (2010) (0)
Abstract LB-242: Aberrant crypt foci (ACF) are not surrogate biomarkers of sporadic adenoma prevention with celecoxib: Results from the Adenoma Prevention with Celecoxib (APC) trial (2008) (0)
Table 4, Efficient (or near efficient) strategies for start age of 50 and stop age of 75. The number of colonoscopies per life-year gained is calculated within screening test category (2009) (0)
Symptoms and care seeking among black and white women with endometrial cancer (2007) (0)
121 PERSONALIZED SCREENING STRATEGIES FOR COLORECTAL CANCER BASED ON GENETIC AND ENVIRONMENTAL RISK: A COST-EFFECTIVENESS ANALYSIS (2021) (0)
W1962 Genetic Variation in the Ugt1a6 Enzyme, Aspirin Use, and Adenoma “Rebound” Associated with Withdrawal of Celecoxib Treatment (2009) (0)
Rates of repeated colonoscopies to clean the colon from low-risk and high-risk adenomas: results from the EPoS trials (2022) (0)
Figure 6.2, Trends in Age-Standardized Incidence and Mortality of Colorectal Cancer Rates in Women, Selected Countries, 1980–2010 (2015) (0)
An interview with Ann Zauber (2020) (0)
EP1351: POTENTIAL IMPACTS OF COMPUTER-AIDED DETECTION OF COLORECTAL POLYPS ON COLONOSCOPY SURVEILLANCE INTERVALS (2022) (0)
S1159 Elimination of Racial Disparities in Screening Colonoscopy Participation by Using a Patient Navigator System: Results From the National Colonoscopy Study (2010) (0)
Benefits and harms of colonoscopy surveillance following colonoscopic polypectomy: report from the National Polyp Study (2000) (0)
Mo1709 Characteristics of Interval Colorectal Cancers - A Retrospective Descriptive Analysis (2016) (0)
119 Impact of Adjusting for Patient Demographics on Physician Adenoma Detection Rates in a Large, Community-Based Setting (2014) (0)
MISCAN-colon: An Overview (2005) (0)
Table 5b, Secondary Outcomes for the Recommendable Set of Efficient Screening Strategies Using Colonoscopy beginning at age 50, Stopping at age 75, and 20 Year Interval as Starting Strategy (2009) (0)
Does the increased colorectal cancer risk in Jewish individuals correlate with characteristics of their adenomas (2000) (0)
Tu1179 Colorectal Cancer Screening Program in the Ontario Population: the Additional Effects of Identifying Individuals With an Increased Risk (2012) (0)
285 - Colorectal Cancer Screening Initiation at Age 45 Years: A Microsimulation Analysis to Address the Rising Incidence in Young Adults (2018) (0)
Cost-Effectiveness Analysis of Colonoscopy Colorectal Cancer Screening in Persons with Cystic Fibrosis (2017) (0)
Repeat Annual Fecal Immunochemical Testing Patterns in a Large Community-Based Integrated Healthcare Setting (2017) (0)
S1037 Colonic Stenting for Malignant Large Bowel Obstruction: Long Term Assessment of Symptoms and Quality of Life (2008) (0)
Mo1694 Comparative Cost-Effectiveness of Multi-Targeted Stool DNA Testing in the Medicare Population (2016) (0)
1164 Adherence to Programmatic Annual Fecal Occult Blood Test (gFOBt) Versus Screening Colonoscopy in African Americans Compared to Whites With Equal Access and Navigation: Observations From National Colonoscopy Study (NCS) (2012) (0)
Appendix 3: Results including starting at age 40 in efficient and near-efficient frontiers (2009) (0)
Edinburgh Research Explorer Germline Variants and Advanced Colorectal Adenomas (2017) (0)
#13-S does subsequent pregnancy influence breast cancer survival? (2002) (0)
Table 6, Subset of strategies for start age of 50 and stop age of 75 varied by overall adherence to screening (see Figure 3) (2009) (0)
Population-Based Colonoscopy Screening for Colorectal Cancer A European Randomized Clinical Trial (2016) (0)
Sa1082 Colorectal Cancer Screening Outreach Targeting Members Older than 75 Years of Age (2016) (0)
Table 9, Summary results for all flexible sigmoidoscopy strategies per 1000 40-year old individuals, MISCAN (2009) (0)
Su1234 A Systematic Review on Diagnostic Test Accuracy of Fecal Immunochemical Tests for Colorectal Cancer Screening (2014) (0)
M1177 Risk of Colorectal Adenoma Recurrence Due to Red Blood Cell Folate Level in the Post Folate Fortification Era: Results From the Adenoma Prevention With Celecoxib (APC) Trial (2010) (0)
Genetic variation in the cytochrome P450 2C9 enzyme and dose of Celecoxib in the prevention of colorectal adenoma (2008) (0)
Impact of immunochemical versus guaic fecal occult blood tests (FOBT) for life years gained (LYG) and cost (2003) (0)
251 Screening Colonoscopy and the Risk of Death From Right and Left Colon Cancers (2016) (0)
S1148 African-Americans Have the Same Prevalence and Proximal Distribution of Adenomas as Whites in the National Colonoscopy Study (2010) (0)
Cost-Effectiveness of Surveillance Guidelines for Patients with Low-Risk or High-Risk Colorectal Adenomas (2017) (0)
A Case-Control Study of Analgesic Use and Ovarian Cancer 1 (2000) (0)
314 Consequences of Delayed Diagnostic Colonoscopy Following a Positive Fecal Immunochemical Test (2014) (0)
Abstract B114: Comparative effectiveness research on colorectal cancer screening (2010) (0)
W1002 Customizing Timing of Screening Colonoscopy: A Predictive Model for Risk of Adenomas (2010) (0)
Mo1996 Validation of Simulation Models to the UK Flexiscope Trial to Inform the Natural History of Colorectal Cancer (2015) (0)
In Memoriam: Wendy Atkin 1947-2018. (2019) (0)
Examining the potential value of faecal immunochemical testing (FIT) in surveillance of post-polypectomy colorectal adenoma using MISCAN micro-simulation cost effectiveness modelling (2017) (0)
Projected long-term effects of colorectal cancer screening disruptions following the COVID-19 pandemic (2023) (0)
Are women with a history of gynecologic cancer at increased risk for colorectal neoplasia (2001) (0)
Unequal Recovery in Colorectal Cancer Screening Following the COVID-19 Pandemic (2022) (0)
314j: National Estimates of Endoscopic Resource Requirements for Delivering Colorectal Cancer Screening (2010) (0)
The Impact of the Rising Colorectal Cancer Incidence in Young Adults on the Optimal Age to Start Screening in the US: A Microsimulation Analysis (2018) (0)
Risk-stratified screening for colorectal cancer using genetic and environmental risk factors: A cost-effectiveness analysis based on real-world data. (2023) (0)
The Impacts of Computer-Aided Detection of Colorectal Polyps on Subsequent Colonoscopy Surveillance Intervals: Simulation Study (2022) (0)
S268 Frequency of Colorectal Neoplasia in Young Onset Colorectal Cancer Does Not Warrant Shorter Surveillance Intervals (2021) (0)
Long-Term Impact of Colorectal Cancer Screening Using a Combination of Fecal Immunochemical Testing and Lower Bowel Endoscopy in a Large, Community-Based Integrated Healthcare Setting (2017) (0)
Tu1082 Factors Influencing Variation in Physician Adenoma Detection Rates: A Theory-Based Approach to Performance Improvement (2015) (0)
99 - Potentially Modifiable Factors in the Screening Process to Prevent Death from Colorectal Cancer (2018) (0)
Critical Appraisal of Decision Models Used for the Economic Evaluation of Bladder Cancer Screening and Diagnosis: A Systematic Review (2023) (0)
Session Title: Epidemiology and Evaluating Patient Outcomes (2012) (0)
Intensity of Surveillance for Patients With Colorectal Adenomas (2020) (0)
Recent trends in cancer survival. (1986) (0)
Systematic Review Protocol to Evaluate the Effectiveness and Cost Effectiveness of Personalised Surveillance after Colorectal Adenomatous Polypectomy (2016) (0)
956 The Effect of an Organized Screening Program on Racial and Ethnic Disparities and Choice of Colorectal Cancer Screening Test (2014) (0)
957 Optimal Colorectal Cancer Screening Strategy for States' Low-Income, Uninsured Populations -The Case of South Carolina (2014) (0)
Outcomes and Quality of Life (QOL) in Patients Undergoing Stenting Or Minimally Invasive Surgical Diversion (MISD) for Palliation of Malignant Large Bowel Obstruction (MLBO) (2006) (0)
Mo1715 Comparison of Resources and Adherence for Annual Fecal Occult Blood Test versus Colonoscopy (CRAFT) Study: Analysis from the National Colonoscopy Study (2016) (0)
Reply. (2018) (0)
Symptom Response and Quality of Life in Patients Undergoing Colorectal Stent Placement (2005) (0)
954 Prevalence of Colorectal Adenomas in Blacks, Whites and Hispanics Having Screening Colonoscopy in a Patient Navigation Program: A Prospective Multicenter Study (2014) (0)
Abstract IA14: Decision analysis for colorectal cancer screening recommendations (2017) (0)
Cost-effectiveness of surveillance with CT colonography after resection of colorectal cancer (2020) (0)
Appendix 2: Summary results per 1000 40-year old individuals for all strategies and both models (2009) (0)
Su1722 PREVALENCE OF COLONIC NEOPLASIA BY AGE AND INDICATION IN THE GIQUIC NATIONAL CLINICAL REGISTRY (2019) (0)
652: IMPACT AND RECOVERY FROM COVID-19-RELATED DISRUPTIONS IN COLORECTAL CANCER SCREENING AND CARE: A SCENARIO ANALYSIS (2022) (0)
A restricted look at CRC screening: not considering annual stool testing as an option. (2016) (0)

This paper list is powered by the following services:

Other Resources About Ann Zauber

en.wikipedia.org

What Schools Are Affiliated With Ann Zauber?

Ann Zauber is affiliated with the following schools:

Ann Zauber's Academic­Influence.com Rankings

Ann Zauber's Degrees

Why Is Ann Zauber Influential?

Ann Zauber's Published Works

Published Works

Other Resources About Ann Zauber

What Schools Are Affiliated With Ann Zauber?

Ann Zauber's AcademicInfluence.com Rankings